Aviance Capital Partners, LLC Moderna, Inc. Transaction History

Aviance Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$126.46 - $235.05 $139,106 - $258,555	-1,100 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$225.82 - $368.51 $10,161 - $16,582	-45 Reduced 3.93%	1,100 $279,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $32,175 - $70,248	145 Added 14.5%	1,145 $441,000
Q2 2021 Aug 06, 2021	BUY	$129.91 - $234.98 $129,910 - $234,980	1,000 New	1,000 $235,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Aviance Capital Partners, LLC with notifications on news.